Alvogen, Lotus launch generic version of Navelbine Softgel capsule in Europe

This article was originally published here

The product is the generic version of Pierre Fabre Médicament’s Navelbine®, which is indicated for the treatment of advanced non-small-cell lung cancer (NSCLC) and advanced breast cancer. The

The post Alvogen, Lotus launch generic version of Navelbine Softgel capsule in Europe appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply